| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve Stenosis | 41 | 2024 | 2018 | 5.190 |
Why?
|
| Coronary Artery Disease | 35 | 2024 | 6506 | 4.790 |
Why?
|
| Acute Coronary Syndrome | 23 | 2024 | 2194 | 4.680 |
Why?
|
| Drug-Eluting Stents | 10 | 2024 | 681 | 4.250 |
Why?
|
| Heart Valve Prosthesis Implantation | 27 | 2024 | 1555 | 3.980 |
Why?
|
| Platelet Aggregation Inhibitors | 20 | 2024 | 2746 | 2.800 |
Why?
|
| Aortic Valve | 35 | 2024 | 1959 | 2.560 |
Why?
|
| Treatment Outcome | 123 | 2024 | 64681 | 2.330 |
Why?
|
| Atrial Fibrillation | 17 | 2024 | 5114 | 2.310 |
Why?
|
| Fibrinolytic Agents | 10 | 2023 | 2075 | 2.260 |
Why?
|
| Coronary Artery Bypass | 11 | 2023 | 2193 | 2.250 |
Why?
|
| Endovascular Procedures | 11 | 2024 | 2181 | 2.220 |
Why?
|
| Thrombosis | 9 | 2023 | 2944 | 2.200 |
Why?
|
| Ultrasonography, Interventional | 10 | 2024 | 1496 | 2.180 |
Why?
|
| Hospital Mortality | 33 | 2024 | 5295 | 2.120 |
Why?
|
| Ventricular Dysfunction, Left | 9 | 2023 | 2131 | 2.010 |
Why?
|
| Acute Kidney Injury | 9 | 2024 | 1923 | 1.890 |
Why?
|
| Coronary Angiography | 22 | 2024 | 4507 | 1.890 |
Why?
|
| Randomized Controlled Trials as Topic | 39 | 2024 | 10218 | 1.880 |
Why?
|
| Heart Valve Prosthesis | 13 | 2023 | 1463 | 1.880 |
Why?
|
| Heart Failure | 24 | 2024 | 11701 | 1.860 |
Why?
|
| Myocardial Infarction | 16 | 2024 | 11476 | 1.810 |
Why?
|
| Shock, Cardiogenic | 9 | 2024 | 709 | 1.700 |
Why?
|
| Hemorrhage | 22 | 2024 | 3422 | 1.640 |
Why?
|
| Anticoagulants | 13 | 2023 | 4795 | 1.620 |
Why?
|
| Renal Dialysis | 7 | 2022 | 1796 | 1.610 |
Why?
|
| Mitral Valve Insufficiency | 10 | 2024 | 1400 | 1.600 |
Why?
|
| Heart-Assist Devices | 11 | 2024 | 1288 | 1.600 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2023 | 1462 | 1.520 |
Why?
|
| Cardiac Valve Annuloplasty | 2 | 2022 | 51 | 1.490 |
Why?
|
| Humans | 281 | 2024 | 761222 | 1.470 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 3 | 2023 | 339 | 1.390 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 3 | 2021 | 536 | 1.380 |
Why?
|
| Stroke | 20 | 2024 | 9721 | 1.340 |
Why?
|
| Pulmonary Embolism | 5 | 2023 | 2571 | 1.340 |
Why?
|
| Peripheral Arterial Disease | 9 | 2024 | 1275 | 1.310 |
Why?
|
| Postoperative Complications | 25 | 2024 | 15637 | 1.300 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2020 | 1724 | 1.260 |
Why?
|
| New York City | 8 | 2022 | 730 | 1.220 |
Why?
|
| Risk Factors | 80 | 2024 | 74241 | 1.210 |
Why?
|
| Coronary Occlusion | 3 | 2024 | 304 | 1.210 |
Why?
|
| Saphenous Vein | 2 | 2021 | 516 | 1.210 |
Why?
|
| Hypertension, Pulmonary | 3 | 2023 | 1592 | 1.190 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2023 | 991 | 1.180 |
Why?
|
| Radial Artery | 5 | 2024 | 187 | 1.180 |
Why?
|
| Femoral Artery | 7 | 2024 | 826 | 1.140 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2022 | 353 | 1.140 |
Why?
|
| Stroke Volume | 14 | 2023 | 5521 | 1.100 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 5 | 2023 | 284 | 1.090 |
Why?
|
| Intra-Aortic Balloon Pumping | 4 | 2024 | 223 | 1.090 |
Why?
|
| Alanine | 4 | 2023 | 608 | 1.080 |
Why?
|
| Registries | 14 | 2024 | 8246 | 1.080 |
Why?
|
| Thrombolytic Therapy | 5 | 2023 | 2055 | 1.060 |
Why?
|
| Hemoglobins | 3 | 2021 | 1525 | 1.050 |
Why?
|
| Renal Insufficiency, Chronic | 6 | 2024 | 2254 | 1.040 |
Why?
|
| Fractional Flow Reserve, Myocardial | 4 | 2024 | 345 | 1.000 |
Why?
|
| Adenosine Monophosphate | 3 | 2021 | 231 | 0.980 |
Why?
|
| Coronary Vessel Anomalies | 3 | 2024 | 307 | 0.970 |
Why?
|
| Bioprosthesis | 4 | 2023 | 591 | 0.960 |
Why?
|
| Retrospective Studies | 64 | 2024 | 80675 | 0.930 |
Why?
|
| Coronavirus Infections | 6 | 2021 | 3093 | 0.930 |
Why?
|
| Patient Readmission | 14 | 2024 | 3265 | 0.930 |
Why?
|
| Steroids | 4 | 2021 | 929 | 0.920 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2024 | 86 | 0.910 |
Why?
|
| Coronary Vessels | 7 | 2024 | 3111 | 0.900 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2021 | 1504 | 0.900 |
Why?
|
| Japan | 12 | 2023 | 1378 | 0.850 |
Why?
|
| Heart Diseases | 4 | 2020 | 2795 | 0.820 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2021 | 1878 | 0.810 |
Why?
|
| Catheterization, Peripheral | 2 | 2024 | 343 | 0.810 |
Why?
|
| Blood Transfusion | 3 | 2024 | 1303 | 0.780 |
Why?
|
| Mitral Valve Annuloplasty | 2 | 2024 | 144 | 0.770 |
Why?
|
| Nose Diseases | 1 | 2022 | 79 | 0.760 |
Why?
|
| Aortic Aneurysm, Abdominal | 6 | 2024 | 1228 | 0.750 |
Why?
|
| Aged | 67 | 2024 | 169292 | 0.750 |
Why?
|
| Heart Transplantation | 10 | 2023 | 3258 | 0.750 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2024 | 695 | 0.740 |
Why?
|
| Blood Vessel Prosthesis Implantation | 4 | 2024 | 1425 | 0.740 |
Why?
|
| Mucormycosis | 1 | 2022 | 102 | 0.730 |
Why?
|
| Coronary Restenosis | 1 | 2023 | 396 | 0.730 |
Why?
|
| Ischemic Attack, Transient | 2 | 2023 | 874 | 0.720 |
Why?
|
| Coronary Aneurysm | 1 | 2023 | 233 | 0.720 |
Why?
|
| Venous Thromboembolism | 3 | 2023 | 1869 | 0.720 |
Why?
|
| Pneumonia, Viral | 5 | 2020 | 3215 | 0.710 |
Why?
|
| Aortic Rupture | 2 | 2020 | 319 | 0.700 |
Why?
|
| Risk Assessment | 30 | 2024 | 24022 | 0.690 |
Why?
|
| Ablation Techniques | 1 | 2023 | 247 | 0.690 |
Why?
|
| Antimetabolites | 1 | 2020 | 129 | 0.690 |
Why?
|
| Male | 90 | 2024 | 360703 | 0.680 |
Why?
|
| Orbital Diseases | 1 | 2022 | 178 | 0.680 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2021 | 1039 | 0.670 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 5842 | 0.670 |
Why?
|
| Troponin | 2 | 2020 | 504 | 0.670 |
Why?
|
| Catheter Ablation | 3 | 2022 | 2751 | 0.670 |
Why?
|
| Troponin I | 2 | 2020 | 652 | 0.650 |
Why?
|
| Pharmacy | 1 | 2021 | 91 | 0.650 |
Why?
|
| Glucosides | 1 | 2024 | 512 | 0.640 |
Why?
|
| Vitamin K | 4 | 2023 | 313 | 0.640 |
Why?
|
| Tomography, Optical Coherence | 3 | 2024 | 2923 | 0.630 |
Why?
|
| Female | 87 | 2024 | 392552 | 0.630 |
Why?
|
| Stents | 8 | 2024 | 3177 | 0.620 |
Why?
|
| Hospitalization | 12 | 2024 | 10707 | 0.610 |
Why?
|
| Vascular Diseases | 2 | 2024 | 1160 | 0.610 |
Why?
|
| Time Factors | 26 | 2024 | 39957 | 0.610 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 311 | 0.610 |
Why?
|
| Inferior Wall Myocardial Infarction | 1 | 2017 | 10 | 0.600 |
Why?
|
| Aged, 80 and over | 34 | 2024 | 58952 | 0.590 |
Why?
|
| Embolism | 1 | 2021 | 399 | 0.590 |
Why?
|
| Heart Arrest | 3 | 2023 | 1513 | 0.590 |
Why?
|
| Endarterectomy, Carotid | 1 | 2023 | 554 | 0.590 |
Why?
|
| Middle Aged | 53 | 2024 | 220858 | 0.580 |
Why?
|
| Drug Therapy, Combination | 4 | 2023 | 6304 | 0.570 |
Why?
|
| Myocardial Revascularization | 5 | 2023 | 794 | 0.570 |
Why?
|
| Mitral Valve | 9 | 2024 | 1465 | 0.560 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 917 | 0.560 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 431 | 0.560 |
Why?
|
| Lower Extremity | 3 | 2023 | 1201 | 0.550 |
Why?
|
| Carotid Artery Diseases | 1 | 2023 | 877 | 0.550 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2023 | 3245 | 0.540 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2022 | 1725 | 0.530 |
Why?
|
| Carotid Stenosis | 1 | 2023 | 859 | 0.510 |
Why?
|
| Myocarditis | 1 | 2023 | 792 | 0.510 |
Why?
|
| Tachycardia, Ventricular | 1 | 2024 | 1305 | 0.490 |
Why?
|
| Anemia | 2 | 2024 | 1504 | 0.490 |
Why?
|
| Pulmonary Veins | 1 | 2021 | 743 | 0.490 |
Why?
|
| Antiviral Agents | 4 | 2023 | 3048 | 0.490 |
Why?
|
| Vaccines | 1 | 2023 | 835 | 0.480 |
Why?
|
| Administration, Oral | 6 | 2023 | 4015 | 0.470 |
Why?
|
| Chest Pain | 2 | 2023 | 1097 | 0.470 |
Why?
|
| Contrast Media | 4 | 2023 | 5311 | 0.470 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 2021 | 0.460 |
Why?
|
| Dyslipidemias | 1 | 2021 | 870 | 0.460 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 842 | 0.450 |
Why?
|
| Patient Admission | 1 | 2021 | 1365 | 0.440 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2023 | 1312 | 0.440 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 527 | 0.440 |
Why?
|
| Behcet Syndrome | 1 | 2014 | 86 | 0.430 |
Why?
|
| Predictive Value of Tests | 10 | 2024 | 15308 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2023 | 3627 | 0.430 |
Why?
|
| Mortality | 4 | 2020 | 2896 | 0.420 |
Why?
|
| Electrocardiography | 4 | 2022 | 6387 | 0.420 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 2631 | 0.420 |
Why?
|
| Paclitaxel | 1 | 2020 | 1730 | 0.420 |
Why?
|
| Aspirin | 3 | 2023 | 3129 | 0.410 |
Why?
|
| Hypercholesterolemia | 3 | 2024 | 1141 | 0.410 |
Why?
|
| Incidence | 16 | 2023 | 21366 | 0.390 |
Why?
|
| Myocardial Ischemia | 1 | 2022 | 2133 | 0.380 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 1003 | 0.370 |
Why?
|
| Aortic Aneurysm | 3 | 2020 | 648 | 0.360 |
Why?
|
| Prosthesis Design | 6 | 2024 | 2114 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 12159 | 0.360 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3210 | 0.350 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3149 | 0.340 |
Why?
|
| Intracranial Embolism | 2 | 2021 | 189 | 0.340 |
Why?
|
| Influenza, Human | 1 | 2020 | 1521 | 0.320 |
Why?
|
| Vascular Patency | 2 | 2023 | 911 | 0.320 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2024 | 2247 | 0.310 |
Why?
|
| Brain Ischemia | 1 | 2022 | 3032 | 0.310 |
Why?
|
| Thrombectomy | 3 | 2022 | 703 | 0.300 |
Why?
|
| Atrial Appendage | 2 | 2022 | 283 | 0.300 |
Why?
|
| Hospitals | 6 | 2023 | 3881 | 0.290 |
Why?
|
| Heart Valve Diseases | 3 | 2020 | 1031 | 0.290 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 2478 | 0.280 |
Why?
|
| Logistic Models | 5 | 2023 | 13249 | 0.280 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2022 | 576 | 0.280 |
Why?
|
| Vaccination | 3 | 2023 | 3369 | 0.270 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 619 | 0.270 |
Why?
|
| Length of Stay | 8 | 2023 | 6417 | 0.270 |
Why?
|
| Dementia | 1 | 2021 | 2684 | 0.260 |
Why?
|
| Blood Coagulation | 2 | 2023 | 1156 | 0.260 |
Why?
|
| Lung | 2 | 2022 | 9979 | 0.260 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2022 | 1162 | 0.260 |
Why?
|
| Biphenyl Compounds | 2 | 2021 | 1007 | 0.250 |
Why?
|
| Ventricular Function, Left | 6 | 2023 | 3899 | 0.250 |
Why?
|
| Palliative Care | 1 | 2020 | 3599 | 0.240 |
Why?
|
| Follow-Up Studies | 10 | 2022 | 39127 | 0.240 |
Why?
|
| Sternotomy | 2 | 2022 | 128 | 0.240 |
Why?
|
| Pandemics | 6 | 2022 | 8663 | 0.230 |
Why?
|
| Cardiomyopathy, Restrictive | 2 | 2022 | 61 | 0.230 |
Why?
|
| Prognosis | 11 | 2024 | 29688 | 0.230 |
Why?
|
| United States | 16 | 2024 | 72341 | 0.230 |
Why?
|
| Plaque, Atherosclerotic | 3 | 2024 | 1535 | 0.230 |
Why?
|
| Comorbidity | 8 | 2024 | 10516 | 0.230 |
Why?
|
| Prospective Studies | 11 | 2023 | 54437 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2024 | 20588 | 0.220 |
Why?
|
| Adult | 29 | 2024 | 221120 | 0.220 |
Why?
|
| Echocardiography | 3 | 2023 | 5006 | 0.220 |
Why?
|
| Limb Salvage | 2 | 2023 | 480 | 0.220 |
Why?
|
| Pacemaker, Artificial | 3 | 2024 | 807 | 0.210 |
Why?
|
| Severity of Illness Index | 11 | 2024 | 15841 | 0.210 |
Why?
|
| Empyema, Pleural | 1 | 2023 | 61 | 0.210 |
Why?
|
| Medicare | 4 | 2024 | 6774 | 0.210 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2024 | 866 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7400 | 0.210 |
Why?
|
| Endarterectomy | 1 | 2023 | 196 | 0.200 |
Why?
|
| Famotidine | 1 | 2021 | 17 | 0.200 |
Why?
|
| Heart Septum | 1 | 2023 | 301 | 0.190 |
Why?
|
| Feasibility Studies | 2 | 2024 | 5250 | 0.190 |
Why?
|
| Bacillus | 1 | 2022 | 77 | 0.190 |
Why?
|
| Bradycardia | 1 | 2023 | 298 | 0.190 |
Why?
|
| Weather | 2 | 2020 | 231 | 0.190 |
Why?
|
| Embolic Protection Devices | 1 | 2021 | 42 | 0.190 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2021 | 18 | 0.190 |
Why?
|
| Natriuretic Peptides | 1 | 2022 | 155 | 0.190 |
Why?
|
| Hypothermia | 1 | 2022 | 188 | 0.180 |
Why?
|
| Neoplasms | 4 | 2023 | 22142 | 0.180 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2021 | 94 | 0.180 |
Why?
|
| Administration, Inhalation | 2 | 2021 | 1159 | 0.180 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2022 | 122 | 0.180 |
Why?
|
| Conjunctivitis, Viral | 1 | 2020 | 6 | 0.180 |
Why?
|
| Aorta, Thoracic | 2 | 2024 | 1096 | 0.180 |
Why?
|
| Cardiovascular Diseases | 4 | 2021 | 15521 | 0.180 |
Why?
|
| Marfan Syndrome | 1 | 2022 | 236 | 0.180 |
Why?
|
| Perindopril | 1 | 2020 | 13 | 0.180 |
Why?
|
| Odds Ratio | 3 | 2021 | 9652 | 0.170 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2022 | 237 | 0.170 |
Why?
|
| Pleural Effusion | 1 | 2023 | 341 | 0.170 |
Why?
|
| Wind | 1 | 2019 | 42 | 0.170 |
Why?
|
| Hypothermia, Induced | 2 | 2022 | 754 | 0.170 |
Why?
|
| Cause of Death | 5 | 2021 | 3688 | 0.170 |
Why?
|
| Prosthesis Failure | 2 | 2023 | 1204 | 0.170 |
Why?
|
| Obesity | 1 | 2021 | 12940 | 0.160 |
Why?
|
| Hospitals, Community | 1 | 2022 | 365 | 0.160 |
Why?
|
| Propensity Score | 6 | 2022 | 1916 | 0.160 |
Why?
|
| Disease Progression | 4 | 2022 | 13511 | 0.160 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.160 |
Why?
|
| Multivariate Analysis | 4 | 2020 | 12052 | 0.160 |
Why?
|
| Postoperative Hemorrhage | 2 | 2019 | 416 | 0.160 |
Why?
|
| Recreation | 1 | 2019 | 125 | 0.160 |
Why?
|
| Albuterol | 1 | 2020 | 211 | 0.160 |
Why?
|
| Risk | 2 | 2022 | 9616 | 0.160 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2021 | 344 | 0.160 |
Why?
|
| Carotid Arteries | 1 | 2023 | 941 | 0.160 |
Why?
|
| Immunization, Passive | 1 | 2021 | 617 | 0.160 |
Why?
|
| Renin-Angiotensin System | 2 | 2021 | 735 | 0.160 |
Why?
|
| Eggs | 1 | 2020 | 182 | 0.160 |
Why?
|
| Critical Illness | 2 | 2021 | 2724 | 0.150 |
Why?
|
| Advance Directives | 1 | 2020 | 249 | 0.150 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2020 | 216 | 0.150 |
Why?
|
| Vasodilator Agents | 1 | 2023 | 989 | 0.150 |
Why?
|
| Recurrence | 3 | 2024 | 8457 | 0.150 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2021 | 373 | 0.150 |
Why?
|
| Peptide Fragments | 2 | 2022 | 5103 | 0.150 |
Why?
|
| Surgical Instruments | 1 | 2020 | 383 | 0.150 |
Why?
|
| Policy | 1 | 2022 | 506 | 0.150 |
Why?
|
| Marriage | 1 | 2019 | 349 | 0.150 |
Why?
|
| Titanium | 1 | 2020 | 490 | 0.150 |
Why?
|
| Atherosclerosis | 2 | 2024 | 3407 | 0.150 |
Why?
|
| Gadolinium | 1 | 2023 | 961 | 0.150 |
Why?
|
| Survival Rate | 6 | 2021 | 12728 | 0.150 |
Why?
|
| Area Under Curve | 1 | 2022 | 1636 | 0.140 |
Why?
|
| Mycoses | 1 | 2020 | 386 | 0.140 |
Why?
|
| Vascular Surgical Procedures | 2 | 2023 | 1489 | 0.140 |
Why?
|
| Adolescent | 8 | 2024 | 88300 | 0.140 |
Why?
|
| Coronary Vasospasm | 1 | 2017 | 81 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 1 | 2020 | 392 | 0.140 |
Why?
|
| Popliteal Artery | 1 | 2019 | 310 | 0.140 |
Why?
|
| Catheters | 2 | 2017 | 426 | 0.140 |
Why?
|
| Mitral Valve Stenosis | 1 | 2019 | 341 | 0.140 |
Why?
|
| Drug Combinations | 2 | 2021 | 2048 | 0.140 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2019 | 273 | 0.140 |
Why?
|
| Age Factors | 7 | 2024 | 18384 | 0.140 |
Why?
|
| Sex Factors | 4 | 2024 | 10553 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2021 | 601 | 0.140 |
Why?
|
| Heart Ventricles | 2 | 2020 | 3813 | 0.140 |
Why?
|
| Primary Prevention | 1 | 2024 | 1185 | 0.140 |
Why?
|
| Extremities | 1 | 2022 | 867 | 0.140 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 488 | 0.140 |
Why?
|
| Television | 1 | 2019 | 407 | 0.140 |
Why?
|
| Pericarditis | 1 | 2018 | 136 | 0.140 |
Why?
|
| Ethanol | 1 | 2023 | 1322 | 0.140 |
Why?
|
| Intracranial Hemorrhages | 1 | 2022 | 809 | 0.130 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2021 | 424 | 0.130 |
Why?
|
| Spironolactone | 1 | 2020 | 412 | 0.130 |
Why?
|
| Sarcoidosis | 1 | 2022 | 537 | 0.130 |
Why?
|
| Respiratory Function Tests | 1 | 2021 | 1685 | 0.130 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 513 | 0.130 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2022 | 558 | 0.130 |
Why?
|
| Tricuspid Valve | 1 | 2019 | 410 | 0.130 |
Why?
|
| Coronary Stenosis | 1 | 2022 | 802 | 0.130 |
Why?
|
| Geriatric Assessment | 1 | 2023 | 1409 | 0.130 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 808 | 0.130 |
Why?
|
| Cold Temperature | 1 | 2019 | 783 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 590 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2023 | 963 | 0.130 |
Why?
|
| Prevalence | 9 | 2024 | 15721 | 0.130 |
Why?
|
| Body Mass Index | 4 | 2022 | 12952 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 828 | 0.130 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 4242 | 0.130 |
Why?
|
| Comprehension | 1 | 2021 | 619 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 1078 | 0.120 |
Why?
|
| Bacteremia | 1 | 2022 | 978 | 0.120 |
Why?
|
| Hemodynamics | 3 | 2020 | 4165 | 0.120 |
Why?
|
| Medical Records | 1 | 2020 | 1409 | 0.120 |
Why?
|
| Child | 5 | 2023 | 80154 | 0.120 |
Why?
|
| Benzimidazoles | 1 | 2020 | 858 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2020 | 1139 | 0.120 |
Why?
|
| Gait | 1 | 2020 | 810 | 0.120 |
Why?
|
| Robotics | 1 | 2021 | 817 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2022 | 865 | 0.120 |
Why?
|
| Patient Discharge | 3 | 2022 | 3441 | 0.110 |
Why?
|
| Tetrazoles | 1 | 2020 | 909 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2020 | 992 | 0.110 |
Why?
|
| Hot Temperature | 1 | 2020 | 1434 | 0.110 |
Why?
|
| Proportional Hazards Models | 4 | 2021 | 12474 | 0.110 |
Why?
|
| Heart Atria | 2 | 2023 | 1349 | 0.110 |
Why?
|
| Anticholesteremic Agents | 1 | 2021 | 968 | 0.110 |
Why?
|
| Hepatitis C, Chronic | 1 | 2021 | 1027 | 0.110 |
Why?
|
| Fontan Procedure | 1 | 2019 | 796 | 0.110 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2013 | 20 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2019 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2023 | 1977 | 0.110 |
Why?
|
| Calcium | 2 | 2023 | 5719 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 1390 | 0.100 |
Why?
|
| Creatinine | 1 | 2018 | 1897 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 1 | 2020 | 793 | 0.100 |
Why?
|
| Forecasting | 1 | 2022 | 2928 | 0.100 |
Why?
|
| Azathioprine | 1 | 2014 | 354 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 1474 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1390 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2159 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 4851 | 0.100 |
Why?
|
| Coronary Thrombosis | 1 | 2015 | 440 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 1182 | 0.100 |
Why?
|
| Glucose | 1 | 2024 | 4342 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2024 | 41496 | 0.100 |
Why?
|
| Social Class | 1 | 2020 | 1993 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2021 | 1579 | 0.090 |
Why?
|
| Endoscopy | 1 | 2021 | 1852 | 0.090 |
Why?
|
| Young Adult | 6 | 2024 | 59222 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2020 | 10088 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 3702 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 2182 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2020 | 1604 | 0.090 |
Why?
|
| Feeding Behavior | 2 | 2020 | 3183 | 0.090 |
Why?
|
| Immunosuppressive Agents | 3 | 2022 | 4190 | 0.090 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 1286 | 0.080 |
Why?
|
| Pulmonary Artery | 2 | 2022 | 1929 | 0.080 |
Why?
|
| Heart | 1 | 2022 | 4431 | 0.080 |
Why?
|
| Prednisone | 1 | 2014 | 1565 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2024 | 9319 | 0.080 |
Why?
|
| Parents | 1 | 2023 | 3564 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2020 | 2515 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1847 | 0.080 |
Why?
|
| Inpatients | 1 | 2020 | 2545 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 1932 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2024 | 4487 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2020 | 2332 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3821 | 0.080 |
Why?
|
| Tissue Donors | 3 | 2022 | 2335 | 0.080 |
Why?
|
| Reoperation | 3 | 2024 | 4303 | 0.070 |
Why?
|
| Inflammation | 2 | 2020 | 10759 | 0.070 |
Why?
|
| Graft Rejection | 4 | 2022 | 4481 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12747 | 0.070 |
Why?
|
| Cities | 2 | 2020 | 541 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3744 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2022 | 5081 | 0.070 |
Why?
|
| Bone Density | 1 | 2020 | 3546 | 0.070 |
Why?
|
| Pain | 1 | 2022 | 5072 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7804 | 0.070 |
Why?
|
| Heart Defects, Congenital | 2 | 2020 | 4673 | 0.070 |
Why?
|
| Temperature | 2 | 2022 | 2219 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3201 | 0.060 |
Why?
|
| Research Design | 1 | 2022 | 6180 | 0.060 |
Why?
|
| Sepsis | 1 | 2020 | 2585 | 0.060 |
Why?
|
| Kidney | 1 | 2021 | 7033 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2023 | 42225 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3354 | 0.060 |
Why?
|
| Angiography | 2 | 2024 | 1597 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2020 | 1818 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2021 | 4679 | 0.060 |
Why?
|
| Ischemia | 2 | 2023 | 1889 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 1419 | 0.050 |
Why?
|
| Mineral Oil | 1 | 2022 | 21 | 0.050 |
Why?
|
| Corn Oil | 1 | 2022 | 28 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4822 | 0.050 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 82 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5321 | 0.050 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2023 | 325 | 0.050 |
Why?
|
| Endoleak | 1 | 2022 | 111 | 0.050 |
Why?
|
| Deoxyribonucleases | 1 | 2023 | 209 | 0.050 |
Why?
|
| Asthma | 1 | 2021 | 6230 | 0.050 |
Why?
|
| Equipment Design | 2 | 2024 | 3510 | 0.050 |
Why?
|
| Aorta, Abdominal | 1 | 2024 | 625 | 0.050 |
Why?
|
| Myocardium | 1 | 2014 | 4746 | 0.050 |
Why?
|
| Graft Survival | 2 | 2022 | 3843 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 29893 | 0.050 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2021 | 143 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2023 | 389 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2014 | 5969 | 0.050 |
Why?
|
| Ramipril | 1 | 2021 | 102 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2020 | 6345 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13632 | 0.040 |
Why?
|
| Intermittent Claudication | 1 | 2023 | 304 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2022 | 271 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 1097 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2021 | 366 | 0.040 |
Why?
|
| Heart-Lung Transplantation | 1 | 2020 | 87 | 0.040 |
Why?
|
| Acute Disease | 2 | 2021 | 7226 | 0.040 |
Why?
|
| Antilymphocyte Serum | 1 | 2021 | 491 | 0.040 |
Why?
|
| Enalapril | 1 | 2021 | 310 | 0.040 |
Why?
|
| Septal Occluder Device | 1 | 2020 | 125 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2024 | 698 | 0.040 |
Why?
|
| Debridement | 1 | 2021 | 493 | 0.040 |
Why?
|
| Coma | 1 | 2022 | 484 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2020 | 252 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2023 | 766 | 0.040 |
Why?
|
| Brain Death | 1 | 2022 | 357 | 0.040 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2022 | 561 | 0.040 |
Why?
|
| Neprilysin | 1 | 2021 | 478 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
| Perfusion | 1 | 2022 | 1390 | 0.040 |
Why?
|
| Physicians, Women | 1 | 2024 | 510 | 0.040 |
Why?
|
| Arteries | 1 | 2022 | 1121 | 0.040 |
Why?
|
| No-Reflow Phenomenon | 1 | 2017 | 16 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2024 | 7965 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2023 | 1812 | 0.030 |
Why?
|
| Cattle | 1 | 2023 | 3818 | 0.030 |
Why?
|
| Reference Standards | 1 | 2020 | 1005 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2023 | 1273 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13386 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2019 | 588 | 0.030 |
Why?
|
| Phenotype | 2 | 2024 | 16575 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 1813 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2023 | 922 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 906 | 0.030 |
Why?
|
| Fever | 1 | 2022 | 1618 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
| Sirolimus | 1 | 2022 | 1540 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2021 | 947 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 1664 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2020 | 915 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2018 | 1132 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2021 | 1330 | 0.030 |
Why?
|
| Iron | 1 | 2023 | 1791 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 2380 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2020 | 832 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 1116 | 0.030 |
Why?
|
| Abdomen | 1 | 2020 | 1128 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2020 | 2195 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 7407 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20982 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 2725 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 1270 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 4822 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 2013 | 293 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1869 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2020 | 1301 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2019 | 1037 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2640 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2019 | 4111 | 0.020 |
Why?
|
| Quality of Life | 2 | 2022 | 13367 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 12976 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 36415 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2020 | 1910 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2981 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2022 | 3410 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2020 | 2092 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 10756 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 2013 | 890 | 0.020 |
Why?
|
| Infant | 2 | 2020 | 36170 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2013 | 1611 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 14610 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 8002 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 1061 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 12985 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20118 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9278 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 6974 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22174 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11733 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 168089 | 0.010 |
Why?
|